Company news
Coherus Oncology, Inc. news in 2022
Coherus Oncology, Inc.'s news releases, calls and decks from 2022, newest first.
Coherus BioSciences Reports Third Quarter 2022 Results and Provides Business Update
November 7, 2022
Coherus BioSciences to Report Third Quarter 2022 Financial Results on November 8th, 2022
October 31, 2022
Coherus to Launch CIMERLI™ (ranibizumab-eqrn) in the United States on October 3, 2022
September 18, 2022
Coherus BioSciences Reports Second Quarter 2022 Results and Provides Business Update
August 3, 2022
FDA Approves Coherus’ CIMERLI™ (ranibizumab-eqrn) as the First and Only Interchangeable Biosimilar to Lucentis® for All Five Indications, with 12 Months of Interchangeability Exclusivity
August 1, 2022
Coherus BioSciences to Report Second Quarter 2022 Financial Results on August 4th, 2022
July 27, 2022
Coherus and Junshi Biosciences Announce FDA Acceptance of Resubmission of BLA for Toripalimab for the Treatment of Nasopharyngeal Carcinoma
July 5, 2022
Coherus BioSciences Appoints Dr. Jill O’Donnell-Tormey to its Board of Directors
May 10, 2022
Coherus BioSciences Reports First Quarter 2022 Results
May 4, 2022
Coherus BioSciences Appoints Charlie Newton to Board of Directors
May 4, 2022
Coherus BioSciences to Report First Quarter 2022 Financial Results on May 5th, 2022
April 28, 2022
Coherus and Junshi Biosciences Announce PD-1 Inhibitor Toripalimab Granted Orphan Drug Designation for Small Cell Lung Cancer in the United States
April 13, 2022
Coherus BioSciences Appoints Rosh Dias, MD, MRCP, Chief Medical Officer
March 14, 2022
Coherus BioSciences Reports Fourth Quarter and Full Year 2021 Results
February 16, 2022
Coherus Names Paul Reider Chief Commercial Officer
February 14, 2022
Coherus BioSciences Appoints Health Care Payer Expert Lee N. Newcomer, M.D., to Board of Directors
February 6, 2022
Coherus and Junshi Biosciences Expand Immuno-Oncology Collaboration to Include TIGIT-Targeted Antibody
January 9, 2022
Coherus BioSciences Secures Credit Financing with Pharmakon Advisors
January 6, 2022